Announced Wed, 1 Oct · 17:08 IST

Scrutinizer''s Report along with voting Results

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

ANG Lifesciences India Limited held its 19th Annual General Meeting on 30 September 2025 via video conferencing, and all seven resolutions were passed. These included adoption of the audited standalone and consolidated financial statements for FY 2024-25, re-appointment of Mr. Rajesh Gupta (DIN: 01423407) as Director retiring by rotation, ratification of Cost Auditor remuneration for FY 2025-26, revision in remuneration of Managing Director Mr. Rajesh Gupta and Whole-time Director Mrs. Saruchi Gupta, and appointment of Secretarial Auditors. Financial statements and secretarial auditor appointment were approved unanimously (100%), while the director-related resolutions received 95.51% support and the cost auditor remuneration got 98.71% support. Only a small minority (1.29% to 1.49%) voted against the remuneration and director-related items. Voting was conducted electronically through NSDL's e-voting platform, supervised by Scrutinizer Anil Singh Negi.

Likely market impact

All routine AGM business was cleared smoothly with strong shareholder backing; the minor dissent (under 5%) on director remuneration revisions is not material and is unlikely to affect the stock price.